JP2010509204A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509204A5
JP2010509204A5 JP2009535151A JP2009535151A JP2010509204A5 JP 2010509204 A5 JP2010509204 A5 JP 2010509204A5 JP 2009535151 A JP2009535151 A JP 2009535151A JP 2009535151 A JP2009535151 A JP 2009535151A JP 2010509204 A5 JP2010509204 A5 JP 2010509204A5
Authority
JP
Japan
Prior art keywords
omega
lipid composition
eicosapentaen
prodrug
docosahexaen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009535151A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509204A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/004590 external-priority patent/WO2008139261A2/en
Publication of JP2010509204A publication Critical patent/JP2010509204A/ja
Publication of JP2010509204A5 publication Critical patent/JP2010509204A5/ja
Pending legal-status Critical Current

Links

JP2009535151A 2006-11-03 2007-11-02 脂肪酸アルコール Pending JP2010509204A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85626706P 2006-11-03 2006-11-03
US85626806P 2006-11-03 2006-11-03
US85626906P 2006-11-03 2006-11-03
SE0602352 2006-11-03
PCT/IB2007/004590 WO2008139261A2 (en) 2006-11-03 2007-11-02 Omega-3 lipid compound

Publications (2)

Publication Number Publication Date
JP2010509204A JP2010509204A (ja) 2010-03-25
JP2010509204A5 true JP2010509204A5 (https=) 2010-12-24

Family

ID=39876685

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535151A Pending JP2010509204A (ja) 2006-11-03 2007-11-02 脂肪酸アルコール

Country Status (10)

Country Link
US (1) US20100266681A1 (https=)
JP (1) JP2010509204A (https=)
KR (1) KR20090077081A (https=)
CN (1) CN101646426A (https=)
BR (1) BRPI0718393A2 (https=)
CA (1) CA2667153A1 (https=)
MX (1) MX2009004339A (https=)
NO (1) NO20092131L (https=)
RU (1) RU2009121007A (https=)
WO (1) WO2008139261A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009134147A1 (en) * 2008-05-02 2009-11-05 Pronova Biopharma Norge As Lipid compositions containing derivatives of epa and dha an their use thereof
GB201009368D0 (en) * 2010-06-04 2010-07-21 Sana Pharma As Dietary formulations
US8691297B2 (en) * 2010-09-01 2014-04-08 Nippon Suisan Kaisha, Ltd. Alcoholic injury mitigating agent
CA2876177C (en) 2012-06-11 2022-06-14 The Cleveland Clinic Foundation Treatment and prevention of cardiovascular disease and thrombosis
CN102860506A (zh) * 2012-08-08 2013-01-09 辽宁省大连海洋渔业集团公司 磷虾油微囊粉及其制备方法
PL2961727T3 (pl) * 2013-02-28 2017-06-30 Pronova Biopharma Norge As Sposób wytwarzania kwasu 2-((5Z,8Z, 11Z,14Z,17Z)-ejkoza-5,8,11,14,17-pentaenyloksy)butanowego
EP2826384A1 (de) 2013-07-16 2015-01-21 Evonik Industries AG Verfahren zur Trocknung von Biomasse
WO2016050552A1 (de) 2014-10-02 2016-04-07 Evonik Degussa Gmbh Verfahren zur herstellung einer pufas enthaltenden biomasse mit hoher zellstabilität
ES2900848T5 (en) 2014-10-02 2025-09-25 Evonik Operations Gmbh Method for preparing an animal feed
US10619175B2 (en) 2014-10-02 2020-04-14 Evonik Operations Gmbh Process for producing a PUFA-containing feedstuff by extruding a PUFA-containing biomass
US11464244B2 (en) 2014-10-02 2022-10-11 Evonik Operations Gmbh Feedstuff of high abrasion resistance and good stability in water, containing PUFAs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01207224A (ja) * 1988-02-10 1989-08-21 Nonogawa Shoji:Kk 頭髪用化粧料及び養毛剤
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
DK1121928T3 (da) * 2000-01-31 2008-03-17 Haerting S A Sammensætninger indeholdende phytosterol- og policosanolestere af fedtsyrer til reduktion af niveauet af blodcholesterol og -triglycerider
CN1665566A (zh) * 2000-09-21 2005-09-07 营养21公司 用铬络合物、共轭脂肪酸和 /或共轭脂肪醇治疗糖尿病、减少身体脂肪、改善胰岛素敏感性、缓解高血糖症和高胆固醇血症的方法和组合物
DK1406641T3 (da) * 2001-06-18 2009-05-04 Neptune Technologies & Bioress Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
CN1665496B (zh) * 2002-05-03 2010-05-05 派普生物保健品公司 Epa和dha在制备二级预防神经性疾患的药物中的用途
CN1309813C (zh) * 2002-08-07 2007-04-11 花王株式会社 油脂组合物
US8017651B2 (en) * 2002-11-22 2011-09-13 Bionexus, Ltd. Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia
AU2004216856A1 (en) * 2003-03-05 2004-09-16 Solvay Pharmaceuticals Gmbh Use of omega-3-fatty acids in the treatment of diabetic patients
SE0303513D0 (sv) * 2003-12-19 2003-12-19 Pronova Biocare As Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof

Similar Documents

Publication Publication Date Title
JP2010509204A5 (https=)
RU2009121007A (ru) Жирные спирты
RU2509071C2 (ru) Новые липидные соединения
US6555700B1 (en) 1,3-propane diol esters and ethers and methods for their use in drug delivery
TW522013B (en) Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
JP6106158B2 (ja) 酸化的網膜疾患
ES2733353T3 (es) Compuestos lípidos para uso en productos cosméticos, como suplemento alimenticio o como un medicamento
JP5552314B2 (ja) 新規脂質化合物
JP2011528350A5 (https=)
HRP20030035A2 (en) Therapeutic combinations of fatty acids
JP2008540394A5 (https=)
EP2094640A1 (en) Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar).
JPH06234644A (ja) 不飽和脂肪酸のエステルおよび該エステルを含有する組成物
RU2014144501A (ru) Депо-составы гидрофобного активного ингредиента и способы их получения
JP2011503057A5 (https=)
US20140088043A1 (en) Omega-3 compositions
JPWO2019208392A1 (ja) 新規プラズマローゲン誘導体
JPS6377817A (ja) 治療用組成物
EP4126057A1 (en) Composition having improved voluntary acceptance
WO2014095628A1 (en) Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa)
JP2018510206A5 (https=)
JP2007524344A (ja) ヒドロキシオレイン酸及び関連化合物の機能性食品添加物としての使用
USRE40546E1 (en) 1,3-Propane diol esters and ethers and methods for their use in drug delivery
JPS6049747A (ja) リン脂質組成物
JP2013184939A (ja) 体重増加抑制剤